

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.14480919 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.85263109 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.85263109 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.85263109 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.85263109 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.85263109 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.85263109 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.65876604 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51329586 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43816947 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.98696603 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.98696603 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.76428943 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76428943 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71954569 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.68951093 |
| 17 | detection of other organism (GO:0098543) | 4.64591434 |
| 18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.46815282 |
| 19 | detection of bacterium (GO:0016045) | 4.46274440 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.40778424 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.33041376 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.32699360 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.26894768 |
| 24 | microglial cell activation (GO:0001774) | 4.25068558 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.11521596 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 4.11075156 |
| 27 | detection of external biotic stimulus (GO:0098581) | 4.03662152 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.00011852 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.99111312 |
| 30 | respiratory burst (GO:0045730) | 3.96160246 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95861288 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.93385569 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90716760 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.89120837 |
| 35 | leukocyte aggregation (GO:0070486) | 3.87482831 |
| 36 | cellular extravasation (GO:0045123) | 3.82646984 |
| 37 | response to peptidoglycan (GO:0032494) | 3.81720120 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.78224871 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.76258282 |
| 40 | response to host immune response (GO:0052572) | 3.76050397 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76050397 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74712011 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66331344 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63790512 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.62639954 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57643376 |
| 47 | response to host (GO:0075136) | 3.56725951 |
| 48 | response to host defenses (GO:0052200) | 3.56725951 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.56725951 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.54612215 |
| 51 | negative regulation of granulocyte differentiation (GO:0030853) | 3.50822935 |
| 52 | tolerance induction (GO:0002507) | 3.50098465 |
| 53 | pinocytosis (GO:0006907) | 3.49349134 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.46055579 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.44079152 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40092881 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.39732286 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.39343464 |
| 59 | T cell migration (GO:0072678) | 3.39318278 |
| 60 | macrophage activation (GO:0042116) | 3.39162160 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37185167 |
| 62 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34758097 |
| 63 | neutrophil activation (GO:0042119) | 3.33106302 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.31076312 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.30293550 |
| 66 | negative T cell selection (GO:0043383) | 3.29249680 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 3.28460283 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 3.25195031 |
| 69 | B cell mediated immunity (GO:0019724) | 3.23424084 |
| 70 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21830588 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20758640 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.19544564 |
| 73 | granulocyte activation (GO:0036230) | 3.18837710 |
| 74 | positive regulation of interferon-beta production (GO:0032728) | 3.18404584 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 3.14528304 |
| 76 | mast cell activation (GO:0045576) | 3.13530820 |
| 77 | leukocyte cell-cell adhesion (GO:0007159) | 3.10589577 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10035468 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 3.09120432 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07801272 |
| 81 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06876510 |
| 82 | interferon-gamma production (GO:0032609) | 3.05836140 |
| 83 | leukocyte degranulation (GO:0043299) | 3.05516948 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 3.04954178 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04461674 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 3.04175717 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04175717 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03896843 |
| 89 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02997324 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 3.02717349 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02111418 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02111418 |
| 93 | positive regulation of chemokine secretion (GO:0090197) | 3.02105273 |
| 94 | negative regulation of innate immune response (GO:0045824) | 3.02040794 |
| 95 | mannose metabolic process (GO:0006013) | 3.00463407 |
| 96 | regulation of mast cell degranulation (GO:0043304) | 3.00208162 |
| 97 | mature B cell differentiation (GO:0002335) | 2.99052777 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98617843 |
| 99 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98433004 |
| 100 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98433004 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.98348183 |
| 102 | neutrophil mediated immunity (GO:0002446) | 2.97342445 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.95742568 |
| 104 | defense response to protozoan (GO:0042832) | 2.95698772 |
| 105 | myeloid leukocyte activation (GO:0002274) | 2.95189589 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95178021 |
| 107 | I-kappaB phosphorylation (GO:0007252) | 2.93544488 |
| 108 | germinal center formation (GO:0002467) | 2.93395649 |
| 109 | response to type I interferon (GO:0034340) | 2.92930662 |
| 110 | T cell selection (GO:0045058) | 2.92237006 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91789590 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.91777261 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.91777261 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.91501963 |
| 115 | negative regulation of type 2 immune response (GO:0002829) | 2.90018535 |
| 116 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87582624 |
| 117 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82757280 |
| 118 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81635828 |
| 119 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.81104788 |
| 120 | response to protozoan (GO:0001562) | 2.80763688 |
| 121 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80141285 |
| 122 | thymic T cell selection (GO:0045061) | 2.79905691 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.79065984 |
| 124 | B cell homeostasis (GO:0001782) | 2.78131041 |
| 125 | response to interleukin-15 (GO:0070672) | 2.76364684 |
| 126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75321274 |
| 127 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.74644361 |
| 128 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72758091 |
| 129 | positive T cell selection (GO:0043368) | 2.71627691 |
| 130 | negative regulation of interleukin-17 production (GO:0032700) | 2.70810346 |
| 131 | negative regulation of B cell proliferation (GO:0030889) | 2.70409445 |
| 132 | cellular defense response (GO:0006968) | 2.69949560 |
| 133 | activated T cell proliferation (GO:0050798) | 2.69604638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.37595320 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25985167 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.54944260 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.12542838 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.01481444 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.96965057 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85443336 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.84743878 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.46672014 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38495131 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.11292359 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02403837 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.00559827 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85195981 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83552057 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72715579 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.63623025 |
| 18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.58062946 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.56926286 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48548726 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.46651505 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46116876 |
| 23 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42739844 |
| 24 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.42182480 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41338959 |
| 26 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40107347 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31999614 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.31722230 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.27156221 |
| 30 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.24697385 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.23402486 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19302025 |
| 33 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15458509 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 2.03348912 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00749062 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98132856 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94177974 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91693602 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88017525 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86307756 |
| 41 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76404725 |
| 42 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73139886 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72610652 |
| 44 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68285819 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58406308 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55538146 |
| 47 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54137652 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53907897 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51846143 |
| 50 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49510682 |
| 51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44672656 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43358993 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41746262 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41465331 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40744344 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37788400 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36641864 |
| 58 | * MAF_26560356_Chip-Seq_TH2_Human | 1.36362078 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35919284 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33146335 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32772749 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32110441 |
| 63 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29097896 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28809447 |
| 65 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27676651 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25587980 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24692778 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21540496 |
| 69 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.21468619 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20369812 |
| 71 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19861967 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19239412 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18888846 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18166118 |
| 75 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17689473 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17209360 |
| 77 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12923272 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10147307 |
| 79 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09213290 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06961619 |
| 81 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05541484 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05416790 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02348673 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01894841 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01623748 |
| 86 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00706098 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99787064 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94739636 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94686855 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93677652 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93522209 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91820946 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91329112 |
| 94 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89433383 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88645673 |
| 96 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85482447 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85026338 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83731841 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82219143 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78569374 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77544079 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76415687 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73967163 |
| 104 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72184842 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70461310 |
| 106 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69851739 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69654522 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69601656 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69208250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.23429640 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.41469846 |
| 3 | MP0003303_peritoneal_inflammation | 3.28255091 |
| 4 | MP0003436_decreased_susceptibility_to | 3.21220542 |
| 5 | MP0006082_CNS_inflammation | 3.20075026 |
| 6 | MP0005671_abnormal_response_to | 3.19538290 |
| 7 | MP0002419_abnormal_innate_immunity | 2.98784008 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.91804996 |
| 9 | MP0001800_abnormal_humoral_immune | 2.86407705 |
| 10 | MP0000685_abnormal_immune_system | 2.82224964 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.77994849 |
| 12 | MP0001790_abnormal_immune_system | 2.75469532 |
| 13 | MP0005387_immune_system_phenotype | 2.75469532 |
| 14 | MP0005025_abnormal_response_to | 2.69074971 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.66473929 |
| 16 | MP0009785_altered_susceptibility_to | 2.66386451 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.61391066 |
| 18 | MP0002723_abnormal_immune_serum | 2.59944415 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.50982693 |
| 20 | MP0001819_abnormal_immune_cell | 2.50227517 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.48342520 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.34160071 |
| 23 | MP0003724_increased_susceptibility_to | 2.22046706 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.14053569 |
| 25 | MP0002405_respiratory_system_inflammati | 2.09097851 |
| 26 | MP0002398_abnormal_bone_marrow | 2.05724039 |
| 27 | MP0004510_myositis | 1.99842795 |
| 28 | MP0000716_abnormal_immune_system | 1.99192452 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.92904644 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.92813628 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.90522790 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.89666385 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.85633363 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.83284333 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.81988282 |
| 36 | MP0009840_abnormal_foam_cell | 1.80952646 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.76730009 |
| 38 | MP0002722_abnormal_immune_system | 1.73922283 |
| 39 | MP0004947_skin_inflammation | 1.73404729 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.72029147 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.65999645 |
| 42 | MP0001853_heart_inflammation | 1.65967335 |
| 43 | MP0002429_abnormal_blood_cell | 1.65207868 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.64041291 |
| 45 | MP0009278_abnormal_bone_marrow | 1.60085041 |
| 46 | MP0008260_abnormal_autophagy | 1.58759696 |
| 47 | MP0008469_abnormal_protein_level | 1.55361645 |
| 48 | MP0001873_stomach_inflammation | 1.55104053 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.51514546 |
| 50 | MP0000343_altered_response_to | 1.49261220 |
| 51 | MP0002006_tumorigenesis | 1.48558435 |
| 52 | MP0005451_abnormal_body_composition | 1.47951560 |
| 53 | MP0003448_altered_tumor_morphology | 1.45172883 |
| 54 | MP0005310_abnormal_salivary_gland | 1.42729595 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.41350541 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.41350541 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.40471307 |
| 58 | MP0003075_altered_response_to | 1.36809156 |
| 59 | MP0002933_joint_inflammation | 1.36569205 |
| 60 | MP0001851_eye_inflammation | 1.31936806 |
| 61 | MP0000858_altered_metastatic_potential | 1.27861115 |
| 62 | MP0002132_abnormal_respiratory_system | 1.26471373 |
| 63 | MP0003690_abnormal_glial_cell | 1.25927785 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.25580832 |
| 65 | MP0000604_amyloidosis | 1.20711151 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.20597641 |
| 67 | MP0010307_abnormal_tumor_latency | 1.20513600 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.19674064 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.11682674 |
| 70 | MP0003866_abnormal_defecation | 1.11260644 |
| 71 | MP0005166_decreased_susceptibility_to | 1.09471275 |
| 72 | MP0000490_abnormal_crypts_of | 1.04675704 |
| 73 | MP0004381_abnormal_hair_follicle | 1.03752901 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.01248651 |
| 75 | MP0009764_decreased_sensitivity_to | 0.97747207 |
| 76 | MP0008004_abnormal_stomach_pH | 0.94517623 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.92228028 |
| 78 | MP0003828_pulmonary_edema | 0.90161411 |
| 79 | MP0009763_increased_sensitivity_to | 0.87459374 |
| 80 | MP0003045_fibrosis | 0.86924904 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.82725494 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.82612390 |
| 83 | MP0000249_abnormal_blood_vessel | 0.81155747 |
| 84 | MP0005390_skeleton_phenotype | 0.77537571 |
| 85 | MP0005023_abnormal_wound_healing | 0.77221164 |
| 86 | MP0000371_diluted_coat_color | 0.76602090 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.73359727 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.73133372 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.67659785 |
| 90 | MP0003795_abnormal_bone_structure | 0.67249190 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.65333117 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.65067944 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.64922054 |
| 94 | MP0008874_decreased_physiological_sensi | 0.62324629 |
| 95 | MP0006054_spinal_hemorrhage | 0.62144829 |
| 96 | MP0002928_abnormal_bile_duct | 0.62119492 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.61785014 |
| 98 | MP0008873_increased_physiological_sensi | 0.61210718 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.60697567 |
| 100 | MP0000609_abnormal_liver_physiology | 0.59963592 |
| 101 | MP0001915_intracranial_hemorrhage | 0.57518790 |
| 102 | MP0001663_abnormal_digestive_system | 0.57452396 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.56816520 |
| 104 | MP0000920_abnormal_myelination | 0.56789493 |
| 105 | MP0002254_reproductive_system_inflammat | 0.55997098 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.55186014 |
| 107 | MP0003091_abnormal_cell_migration | 0.54756862 |
| 108 | MP0003279_aneurysm | 0.51882376 |
| 109 | MP0000598_abnormal_liver_morphology | 0.51485707 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.51345061 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.51303999 |
| 112 | MP0004130_abnormal_muscle_cell | 0.51278343 |
| 113 | MP0004883_abnormal_blood_vessel | 0.51010102 |
| 114 | MP0003329_amyloid_beta_deposits | 0.49628785 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.47777315 |
| 116 | MP0005164_abnormal_response_to | 0.47200972 |
| 117 | MP0001958_emphysema | 0.46841015 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.46190834 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.46089924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.51592091 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.78023393 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.68465772 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.44964055 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.55446646 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.52918841 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.29548836 |
| 8 | Myositis (HP:0100614) | 4.21855280 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.17376261 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.17376261 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.17376261 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.02895602 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96779236 |
| 14 | Glomerulonephritis (HP:0000099) | 3.95911987 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.94342810 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.89391762 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.88427365 |
| 18 | Recurrent skin infections (HP:0001581) | 3.81794673 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.71791565 |
| 20 | Encephalitis (HP:0002383) | 3.64873147 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.61515368 |
| 22 | Recurrent viral infections (HP:0004429) | 3.55515365 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.45530953 |
| 24 | IgM deficiency (HP:0002850) | 3.41481146 |
| 25 | Obstructive lung disease (HP:0006536) | 3.37634272 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.37634272 |
| 27 | Orchitis (HP:0100796) | 3.29912270 |
| 28 | Chronic otitis media (HP:0000389) | 3.28071873 |
| 29 | Gingivitis (HP:0000230) | 3.16893943 |
| 30 | Disinhibition (HP:0000734) | 3.13276872 |
| 31 | Colitis (HP:0002583) | 3.13056193 |
| 32 | Cellulitis (HP:0100658) | 3.11810613 |
| 33 | Inflammation of the large intestine (HP:0002037) | 3.10292432 |
| 34 | Stomatitis (HP:0010280) | 3.08938696 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08296472 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08296472 |
| 37 | Optic neuritis (HP:0100653) | 3.04444252 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 3.04444252 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00054568 |
| 40 | Mucopolysacchariduria (HP:0008155) | 3.00054568 |
| 41 | Meningitis (HP:0001287) | 2.99463192 |
| 42 | Pustule (HP:0200039) | 2.98669859 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.98059926 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.95525716 |
| 45 | Hematochezia (HP:0002573) | 2.94464044 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.92469139 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.89714435 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86988821 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86988821 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86988821 |
| 51 | Agnosia (HP:0010524) | 2.83023568 |
| 52 | Vasculitis (HP:0002633) | 2.82178143 |
| 53 | Periodontitis (HP:0000704) | 2.75087088 |
| 54 | Complement deficiency (HP:0004431) | 2.67619327 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.64963195 |
| 56 | Amyloidosis (HP:0011034) | 2.63300129 |
| 57 | Episodic fever (HP:0001954) | 2.63243814 |
| 58 | Nasal polyposis (HP:0100582) | 2.59986157 |
| 59 | Pulmonary embolism (HP:0002204) | 2.58865131 |
| 60 | Anorexia (HP:0002039) | 2.57265398 |
| 61 | Arterial thrombosis (HP:0004420) | 2.56948014 |
| 62 | Leukocytosis (HP:0001974) | 2.56053880 |
| 63 | Loss of speech (HP:0002371) | 2.55565456 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.54649113 |
| 65 | Axonal loss (HP:0003447) | 2.53920762 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.53505282 |
| 67 | Thrombocytosis (HP:0001894) | 2.52745619 |
| 68 | Abnormality of complement system (HP:0005339) | 2.49592660 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.48425989 |
| 70 | Petechiae (HP:0000967) | 2.48091238 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.47297695 |
| 72 | Increased IgM level (HP:0003496) | 2.47111687 |
| 73 | Hypochromic anemia (HP:0001931) | 2.46884625 |
| 74 | Osteomyelitis (HP:0002754) | 2.46152233 |
| 75 | Thoracic kyphosis (HP:0002942) | 2.44155764 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.42949969 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.42345882 |
| 78 | Impaired platelet aggregation (HP:0003540) | 2.41787876 |
| 79 | Abnormal platelet function (HP:0011869) | 2.41787876 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.40741881 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.36616331 |
| 82 | Gangrene (HP:0100758) | 2.36347663 |
| 83 | T lymphocytopenia (HP:0005403) | 2.35876588 |
| 84 | Myocardial infarction (HP:0001658) | 2.35377309 |
| 85 | Chronic diarrhea (HP:0002028) | 2.34635202 |
| 86 | Nephritis (HP:0000123) | 2.34367459 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.32125684 |
| 88 | Epistaxis (HP:0000421) | 2.28993413 |
| 89 | Abnormality of T cell number (HP:0011839) | 2.28395862 |
| 90 | Purpura (HP:0000979) | 2.25510730 |
| 91 | Eosinophilia (HP:0001880) | 2.25358025 |
| 92 | Sepsis (HP:0100806) | 2.24829513 |
| 93 | Increased serum ferritin (HP:0003281) | 2.24702855 |
| 94 | Basal ganglia calcification (HP:0002135) | 2.24083552 |
| 95 | Abnormality of T cells (HP:0002843) | 2.22799343 |
| 96 | Agammaglobulinemia (HP:0004432) | 2.21747969 |
| 97 | Hemoptysis (HP:0002105) | 2.21635150 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.16498580 |
| 99 | Urticaria (HP:0001025) | 2.15591434 |
| 100 | Peritonitis (HP:0002586) | 2.14604143 |
| 101 | Lymphopenia (HP:0001888) | 2.14391066 |
| 102 | Spondylolisthesis (HP:0003302) | 2.13598993 |
| 103 | Polyneuropathy (HP:0001271) | 2.10231291 |
| 104 | Cerebral aneurysm (HP:0004944) | 2.10030253 |
| 105 | Gingival bleeding (HP:0000225) | 2.09605484 |
| 106 | Glomerulopathy (HP:0100820) | 2.09139298 |
| 107 | Increased IgE level (HP:0003212) | 2.06072414 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.06043285 |
| 109 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04916576 |
| 110 | Vertigo (HP:0002321) | 2.04273745 |
| 111 | Abnormality of the endocardium (HP:0004306) | 2.03865289 |
| 112 | Thyroiditis (HP:0100646) | 2.03381669 |
| 113 | Premature loss of primary teeth (HP:0006323) | 2.02293941 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.02248279 |
| 115 | Abnormality of eosinophils (HP:0001879) | 2.00391612 |
| 116 | Acne (HP:0001061) | 1.99320212 |
| 117 | Chest pain (HP:0100749) | 1.99166568 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.98860945 |
| 119 | Recurrent pneumonia (HP:0006532) | 1.98728495 |
| 120 | J-shaped sella turcica (HP:0002680) | 1.98473004 |
| 121 | Abnormality of the lumbar spine (HP:0100712) | 1.98053759 |
| 122 | Gastrointestinal stroma tumor (HP:0100723) | 1.97717904 |
| 123 | Granulocytopenia (HP:0001913) | 1.96250577 |
| 124 | Keratitis (HP:0000491) | 1.96034765 |
| 125 | Abnormality of the thoracic spine (HP:0100711) | 1.95630688 |
| 126 | Microcytic anemia (HP:0001935) | 1.94820224 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.93052701 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92793785 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.91392288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.47221268 |
| 2 | TGFBR2 | 3.45535186 |
| 3 | BLK | 3.11677489 |
| 4 | TYK2 | 3.09123362 |
| 5 | KIT | 2.83903063 |
| 6 | IRAK4 | 2.82000039 |
| 7 | CSF1R | 2.64307134 |
| 8 | TXK | 2.62815697 |
| 9 | ZAP70 | 2.51333162 |
| 10 | RIPK4 | 2.48662221 |
| 11 | TBK1 | 2.45995778 |
| 12 | STK10 | 2.26530878 |
| 13 | MAP3K14 | 2.08792759 |
| 14 | JAK3 | 2.06423490 |
| 15 | PRPF4B | 2.04056190 |
| 16 | FES | 1.97957960 |
| 17 | JAK1 | 1.97915540 |
| 18 | ERN1 | 1.97288932 |
| 19 | BTK | 1.95034321 |
| 20 | IRAK3 | 1.86804481 |
| 21 | ITK | 1.83899513 |
| 22 | IKBKE | 1.82706397 |
| 23 | SYK | 1.77587249 |
| 24 | HCK | 1.75030743 |
| 25 | CSK | 1.71466672 |
| 26 | TAOK1 | 1.71108167 |
| 27 | TEC | 1.63485876 |
| 28 | LCK | 1.57761879 |
| 29 | TAOK3 | 1.48030609 |
| 30 | IKBKB | 1.47990084 |
| 31 | MAP3K13 | 1.44941986 |
| 32 | MAP2K3 | 1.42617957 |
| 33 | SIK2 | 1.41027135 |
| 34 | EPHB1 | 1.38958365 |
| 35 | TRIB3 | 1.38309696 |
| 36 | CLK1 | 1.37558125 |
| 37 | PKN2 | 1.36965333 |
| 38 | CAMK1D | 1.36226771 |
| 39 | GRK6 | 1.31363324 |
| 40 | LYN | 1.28228588 |
| 41 | EEF2K | 1.21038375 |
| 42 | GRK7 | 1.19453261 |
| 43 | MAP3K1 | 1.16688845 |
| 44 | FGFR4 | 1.07620726 |
| 45 | BMPR2 | 1.07389101 |
| 46 | JAK2 | 1.06686630 |
| 47 | PAK4 | 1.04033359 |
| 48 | LRRK2 | 1.03157208 |
| 49 | MARK3 | 1.02588314 |
| 50 | NEK9 | 1.00007572 |
| 51 | CAMK1G | 0.99498602 |
| 52 | TAOK2 | 0.99045063 |
| 53 | KSR2 | 0.97964709 |
| 54 | NME2 | 0.97796049 |
| 55 | RPS6KA4 | 0.96074090 |
| 56 | FGR | 0.92092113 |
| 57 | MARK2 | 0.90458696 |
| 58 | MATK | 0.90097718 |
| 59 | TTN | 0.88984130 |
| 60 | PIM1 | 0.88525567 |
| 61 | FGFR3 | 0.87939349 |
| 62 | MAP3K10 | 0.87594297 |
| 63 | IRAK1 | 0.87243154 |
| 64 | CDC42BPA | 0.79610234 |
| 65 | YES1 | 0.79523312 |
| 66 | PRKD2 | 0.78066874 |
| 67 | PTK6 | 0.77607778 |
| 68 | CHUK | 0.71929617 |
| 69 | IRAK2 | 0.70060651 |
| 70 | TRPM7 | 0.69130119 |
| 71 | RIPK1 | 0.65805161 |
| 72 | FLT3 | 0.63478463 |
| 73 | PIK3CG | 0.63173225 |
| 74 | CDK6 | 0.61957793 |
| 75 | CAMKK2 | 0.59718893 |
| 76 | SCYL2 | 0.59242239 |
| 77 | TESK2 | 0.58808543 |
| 78 | HIPK2 | 0.55348513 |
| 79 | PDK1 | 0.54679994 |
| 80 | MAP3K5 | 0.53893196 |
| 81 | EGFR | 0.53860922 |
| 82 | MAPK15 | 0.53807181 |
| 83 | MAP3K6 | 0.52496770 |
| 84 | KDR | 0.51196131 |
| 85 | MAP2K6 | 0.51110277 |
| 86 | STK4 | 0.51017151 |
| 87 | PRKCQ | 0.50396871 |
| 88 | PRKCH | 0.48919422 |
| 89 | DYRK1B | 0.48817846 |
| 90 | ABL1 | 0.48762220 |
| 91 | PIM2 | 0.48675224 |
| 92 | EPHA3 | 0.46680144 |
| 93 | MAPKAPK2 | 0.45647259 |
| 94 | MAP3K7 | 0.45571649 |
| 95 | MAPK12 | 0.45557693 |
| 96 | STK11 | 0.43973618 |
| 97 | RPS6KA6 | 0.43649532 |
| 98 | PTK2B | 0.43144546 |
| 99 | MAPK4 | 0.42125069 |
| 100 | CDK4 | 0.41105743 |
| 101 | TNK2 | 0.40755865 |
| 102 | FYN | 0.40718601 |
| 103 | PRKCD | 0.40598262 |
| 104 | IGF1R | 0.40137856 |
| 105 | CDK12 | 0.39834296 |
| 106 | CDK19 | 0.39554567 |
| 107 | RAF1 | 0.39102089 |
| 108 | MAP3K8 | 0.37321215 |
| 109 | SGK3 | 0.37285197 |
| 110 | NLK | 0.35913662 |
| 111 | MOS | 0.35268473 |
| 112 | NEK2 | 0.34978631 |
| 113 | RPS6KC1 | 0.34349508 |
| 114 | RPS6KL1 | 0.34349508 |
| 115 | MAP3K2 | 0.34168365 |
| 116 | MAP3K3 | 0.34044268 |
| 117 | DAPK2 | 0.32277214 |
| 118 | MAP3K11 | 0.31659648 |
| 119 | CAMKK1 | 0.31236730 |
| 120 | SIK3 | 0.30715101 |
| 121 | MAPK11 | 0.29775006 |
| 122 | MAP2K2 | 0.29676451 |
| 123 | ADRBK2 | 0.29137377 |
| 124 | SIK1 | 0.28901257 |
| 125 | ACVR1B | 0.28374270 |
| 126 | KSR1 | 0.27303473 |
| 127 | ALK | 0.26016964 |
| 128 | PDPK1 | 0.24793653 |
| 129 | PDGFRB | 0.24468071 |
| 130 | MAPK7 | 0.24193643 |
| 131 | CDK9 | 0.24087288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.54190464 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14224956 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.88460274 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.87909571 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.79547091 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.60012609 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.39712185 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.38881938 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36678047 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19814243 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15891794 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14291910 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14247295 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.11824483 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.10660804 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.00822077 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.95464019 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81058685 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.76993244 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74979017 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74645032 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.73178828 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62592419 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.62332966 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60184099 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59975296 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53512234 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50265855 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45970811 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45236155 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.44284610 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39130920 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.37221846 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37166899 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35078408 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31268309 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.30857588 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.29073320 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.27812615 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.27179329 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.18194245 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17378246 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14386094 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14198798 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.13088423 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09592187 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08070654 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06462303 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04099333 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03876809 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01988218 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98454331 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92996074 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88845427 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85721650 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85439136 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84957270 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.84479253 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.80286648 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72957615 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72358509 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71986484 |
| 63 | * Endocytosis_Homo sapiens_hsa04144 | 0.66051162 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63930260 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63432921 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62562824 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.60403552 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59683237 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59673644 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57209424 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57143722 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55660961 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55252292 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55180146 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55094775 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54476034 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53831813 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.51735421 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49529110 |
| 80 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48774262 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46100371 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45182314 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45040815 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44027805 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42404584 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40530345 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39250006 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39092826 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38386023 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.37616973 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36434107 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36074466 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34909598 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.33455654 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32609739 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32312681 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31402882 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30943461 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28802721 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27511994 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27068267 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26980141 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24536990 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24206353 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23929008 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23184057 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22715449 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22426320 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22292953 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19341119 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18871599 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15313918 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.14964119 |

